Cargando…

Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy

Detalles Bibliográficos
Autores principales:	Attallah, Nizar, Gupta, Sudeendra, Madhyastha, Rakesh, El Nekidy, Wasim S., Mallat, Jihad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972825/ https://www.ncbi.nlm.nih.gov/pubmed/33746074 http://dx.doi.org/10.1016/j.accpm.2021.100841

Ejemplares similares

Tocilizumab Use in a Chronic Hemodialysis Patient for the Management of COVID-19-Associated Pneumonia and Acute Respiratory Distress Syndrome
por: Gupta, Sudeendra, et al.
Publicado: (2020)

Thromboelastography findings in critically ill COVID-19 patients
por: Salem, Nouran, et al.
Publicado: (2020)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Revised algorithm for heparin anticoagulation during continuous renal replacement therapy
por: Dickie, Helen, et al.
Publicado: (2015)

Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers
por: Atallah, Bassam, et al.
Publicado: (2020)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

Renal replacement therapy in severe COVID-19 patients: Intermittent or continuous, the ongoing debate
por: Gaudray, Eliott, et al.
Publicado: (2021)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Citrate anticoagulation for continuous renal replacement therapy in small children
por: Soltysiak, Jolanta, et al.
Publicado: (2013)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023)

To Compare Acute Peritoneal Dialysis with Sustained Low-efficiency Dialysis in Critically Ill Patients Requiring Renal Replacement Therapy
por: Datt, B., et al.
Publicado: (2017)

Successful treatment of multidrug resistant Klebsiella pneumoniae using dual carbapenem regimen in immunocompromised patient
por: El Nekidy, Wasim S., et al.
Publicado: (2017)

Tocilizumab and COVID-19: Timing of Administration and Efficacy
por: Abidi, Emna, et al.
Publicado: (2022)

Renal long-term outcome of critically ill COVID-19 patients with acute kidney failure and continuous renal replacement therapy
por: Melero, Rosa, et al.
Publicado: (2021)

Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy
por: Vargas Hein, O, et al.
Publicado: (2000)

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011)

Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy
por: Bouchard, Josée, et al.
Publicado: (2009)

The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East
por: Manla, Yosef, et al.
Publicado: (2023)

Hypercoagulability and Anticoagulation in Patients With COVID-19 Requiring Renal Replacement Therapy
por: Roberts, Lara N., et al.
Publicado: (2020)

Continuous renal replacement and removal of inflammatory mediators in sepsis: Still an open debate
por: Buonanno, Pasquale, et al.
Publicado: (2021)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Nocardial Infection in the Early Period after Kidney Transplantation
por: Gupta, Sudeendra, et al.
Publicado: (2022)

Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
por: Raymakers-Janssen, Paulien A. M. A., et al.
Publicado: (2017)

Regional Citrate Anticoagulation and Systemic Anticoagulation during Pediatric Continuous Renal Replacement Therapy: A Systematic Literature Review
por: Buccione, Emanuele, et al.
Publicado: (2022)

Clearance of micronutrients during continuous renal replacement therapy
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

The furosemide stress test to predict renal function after continuous renal replacement therapy
por: van der Voort, Peter HJ, et al.
Publicado: (2014)

Distinction between induction and maintenance dosing in continuous renal replacement therapy
por: MacLaren, Graeme
Publicado: (2011)

‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
por: Honore, Patrick M, et al.
Publicado: (2015)

Endocan is a reliable biomarker during continuous renal replacement therapy
por: Hureau, Maxence, et al.
Publicado: (2019)

Anticoagulation during Renal Replacement Therapy
por: Singh, Simran
Publicado: (2020)

Cardiac dysfunction in pediatric patients on renal replacement therapy
por: Polak-Jonkisz, Dorota, et al.
Publicado: (2012)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure
por: Rodriguez, Keila, et al.
Publicado: (2017)

Predicting the requirement for renal replacement therapy in intensive care patients with sepsis
por: Nierhaus, Axel, et al.
Publicado: (2018)

Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
por: Minhas, Abdul Mannan Khan, et al.
Publicado: (2017)

Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?
por: Jacobs, Rita, et al.
Publicado: (2015)

The hepatitis virus infection and renal replacement therapies: What is the relation?
por: Pustake, Manas, et al.
Publicado: (2022)

High rates of long-term renal recovery in survivors of coronavirus disease 2019–associated acute kidney injury requiring kidney replacement therapy
por: Stockmann, Helena, et al.
Publicado: (2021)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g4jdrte9a630mdf7l7e1bbeb4t